Report #2900342

Overview

Sex

Male

Age

Age unknown

State

NC

Recovered

Recovered

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

the bilateral rash was on his back; This non-serious case was reported by a nurse via sales rep and described the occurrence of rash in a elderly male patient who received Herpes zoster (Shingrix) suspension for injection in pre-filled syringe for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced rash (Verbatim: the bilateral rash was on his back). The outcome of the rash was resolved. The reporter considered the rash to be unrelated to Shingrix. It was unknown if the reporter considered the rash to be related to Shingrix Pre-Filled Syringe Device. The company considered the rash to be unrelated to Shingrix. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-JUN-2026 The patient was in his 90s and had received the Shingrix at a pharmacy. It was unknown how soon after that the patient broke out in a rash on his back. It was not serious. The reporter did not see a provider until about three months after the incident. The batch number was not provided upon follow up with the reporter.